H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) dropped 0% on Wednesday. The stock traded as low as $22.00 and last traded at $22.00. 7,500 shares were traded during mid-day trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.0050.
H. Lundbeck A/S Trading Down 0.0%
The business’s 50 day simple moving average is $22.00 and its 200-day simple moving average is $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The stock has a market capitalization of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68.
About H. Lundbeck A/S
H. Lundbeck A/S is a Denmark-based pharmaceutical company focused on developing and commercializing treatments for disorders of the brain. Its research and product activities primarily address psychiatry and neurology, including depression, schizophrenia, bipolar disorder, migraine, epilepsy and other conditions affecting the central nervous system.
The company’s medicines include Trintellix (vortioxetine) for major depressive disorder, Rexulti (brexpiprazole) for certain psychiatric conditions, Vyepti (eptinezumab) for migraine prevention, and therapies such as Sabril and Onfi for seizure-related disorders.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
